ID23013A - Bahan-bahan farmakologi - Google Patents
Bahan-bahan farmakologiInfo
- Publication number
- ID23013A ID23013A IDW991132A ID991132A ID23013A ID 23013 A ID23013 A ID 23013A ID W991132 A IDW991132 A ID W991132A ID 991132 A ID991132 A ID 991132A ID 23013 A ID23013 A ID 23013A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmacological ingredients
- pharmacological
- ingredients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4279597P | 1997-04-07 | 1997-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23013A true ID23013A (id) | 1999-12-30 |
Family
ID=21923795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991132A ID23013A (id) | 1997-04-07 | 1998-04-06 | Bahan-bahan farmakologi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6242462B1 (id) |
| EP (1) | EP0980358A4 (id) |
| JP (1) | JP2001521505A (id) |
| KR (1) | KR20010006075A (id) |
| CN (1) | CN1259126A (id) |
| AU (1) | AU734657B2 (id) |
| BR (1) | BR9809071A (id) |
| CA (1) | CA2285192A1 (id) |
| EA (1) | EA199900912A1 (id) |
| HU (1) | HUP0002030A3 (id) |
| ID (1) | ID23013A (id) |
| IL (1) | IL132086A0 (id) |
| NO (1) | NO994850L (id) |
| NZ (1) | NZ337827A (id) |
| PL (1) | PL336068A1 (id) |
| TR (1) | TR199902449T2 (id) |
| WO (1) | WO1998045270A1 (id) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5591900A (en) | 1999-07-06 | 2001-01-22 | Eli Lilly And Company | Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid |
| TR200200066T2 (tr) | 1999-07-06 | 2002-04-22 | Eli Lilly And Company | Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri |
| US6579886B2 (en) | 1999-12-22 | 2003-06-17 | Eli Lilly And Company | Selective iglur5 receptor antagonists |
| WO2002053556A2 (en) | 2001-01-05 | 2002-07-11 | Eli Lilly And Company | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| WO2002053139A2 (en) * | 2001-01-05 | 2002-07-11 | Eli Lilly And Company | Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders |
| AU2002227020A1 (en) | 2001-01-05 | 2002-07-16 | Eli Lilly And Company | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| US6924294B2 (en) | 2001-01-05 | 2005-08-02 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP2166003A1 (en) * | 2001-01-05 | 2010-03-24 | Eli Lilly & Company | Excitatory amino acid receptor antagonists |
| US7205313B2 (en) | 2001-01-05 | 2007-04-17 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| WO2002058691A1 (en) * | 2001-01-23 | 2002-08-01 | Neurosearch A/S | Use of non-competitive and selective glur5 antagonists as glutamate receptor modulating compounds |
| ES2398225T3 (es) | 2002-04-26 | 2013-03-14 | Eli Lilly And Company | Derivados de éster de un ácido DECAHIDROISOQUINOLIN-3-CARBOXÍLICO como analgésicos |
| WO2005007106A2 (en) * | 2003-07-10 | 2005-01-27 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a non-nmda glutamate modulator for the treatment of central nervous system damage |
| EP1715921B1 (en) * | 2003-09-25 | 2013-04-24 | Abraxis BioScience, Inc. | Tetrahydroindolone derivatives for treatment of neurological conditions |
| US20050107439A1 (en) * | 2003-11-10 | 2005-05-19 | Helton David R. | Composition and method for treating emesis |
| JP2010510314A (ja) | 2006-11-22 | 2010-04-02 | シーサイド セラピューティクス，エルエルシー | 精神遅滞、ダウン症候群、脆弱ｘ症候群および自閉症の治療方法 |
| WO2008088820A2 (en) | 2007-01-16 | 2008-07-24 | The Johns Hopkins University | Glutamate receptor antagonists and methods of use |
| EP2219648A4 (en) * | 2007-11-09 | 2010-11-03 | Cenomed Biosciences Llc | TREATMENT OF POSTRAUMATIC STRESS WITH TETRAHYDROINDOLONE ARYLPIPERAZINE COMPOUNDS |
| US20090264443A1 (en) * | 2008-04-18 | 2009-10-22 | David Helton | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds |
| EP2544688B1 (en) | 2010-03-02 | 2016-09-07 | President and Fellows of Harvard College | Methods and compositions for treatment of angelman syndrome |
| WO2011150380A1 (en) | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Methods of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
| WO2012009646A1 (en) | 2010-07-15 | 2012-01-19 | Xenoport, Inc. | Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| KR101746944B1 (ko) * | 2015-09-23 | 2017-06-14 | 주식회사 포스코 | 도장 선영성이 우수한 도금강판의 제조방법 및 이에 의해 제조된 도금강판 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5446051A (en) | 1994-05-31 | 1995-08-29 | Eli Lilly And Company | Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists |
| JPH11501619A (ja) * | 1995-02-15 | 1999-02-09 | ベアーズデン バイオ，インコーポレイテッド | アルキルカルボキシアミノ酸−カイネートレセプターのモジュレーター |
-
1998
- 1998-04-06 CA CA002285192A patent/CA2285192A1/en not_active Abandoned
- 1998-04-06 EA EA199900912A patent/EA199900912A1/ru unknown
- 1998-04-06 BR BR9809071-2A patent/BR9809071A/pt not_active IP Right Cessation
- 1998-04-06 WO PCT/US1998/006905 patent/WO1998045270A1/en not_active Application Discontinuation
- 1998-04-06 EP EP98915346A patent/EP0980358A4/en not_active Withdrawn
- 1998-04-06 CN CN98805687A patent/CN1259126A/zh active Pending
- 1998-04-06 KR KR1019997009153A patent/KR20010006075A/ko not_active Application Discontinuation
- 1998-04-06 ID IDW991132A patent/ID23013A/id unknown
- 1998-04-06 US US09/402,174 patent/US6242462B1/en not_active Expired - Fee Related
- 1998-04-06 PL PL98336068A patent/PL336068A1/xx unknown
- 1998-04-06 AU AU69555/98A patent/AU734657B2/en not_active Ceased
- 1998-04-06 HU HU0002030A patent/HUP0002030A3/hu unknown
- 1998-04-06 NZ NZ337827A patent/NZ337827A/xx unknown
- 1998-04-06 TR TR1999/02449T patent/TR199902449T2/xx unknown
- 1998-04-06 JP JP54212798A patent/JP2001521505A/ja active Pending
- 1998-04-06 IL IL13208698A patent/IL132086A0/xx unknown
-
1999
- 1999-10-05 NO NO994850A patent/NO994850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2285192A1 (en) | 1998-10-15 |
| AU6955598A (en) | 1998-10-30 |
| TR199902449T2 (xx) | 2000-07-21 |
| US6242462B1 (en) | 2001-06-05 |
| NO994850D0 (no) | 1999-10-05 |
| NZ337827A (en) | 2000-12-22 |
| WO1998045270A1 (en) | 1998-10-15 |
| BR9809071A (pt) | 2000-08-01 |
| EP0980358A4 (en) | 2001-02-07 |
| AU734657B2 (en) | 2001-06-21 |
| KR20010006075A (ko) | 2001-01-15 |
| EA199900912A1 (ru) | 2000-04-24 |
| PL336068A1 (en) | 2000-06-05 |
| EP0980358A1 (en) | 2000-02-23 |
| IL132086A0 (en) | 2001-03-19 |
| NO994850L (no) | 1999-10-05 |
| HUP0002030A2 (hu) | 2001-04-28 |
| JP2001521505A (ja) | 2001-11-06 |
| CN1259126A (zh) | 2000-07-05 |
| HUP0002030A3 (en) | 2002-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA93198A (de) | Fluoxetinpellets | |
| ID23013A (id) | Bahan-bahan farmakologi | |
| ATA111897A (de) | Kimme | |
| NO20002555D0 (no) | Skjøt | |
| ATE236897T1 (de) | 3-benzylpiperidine | |
| ATA112597A (de) | Snowboard - bindung | |
| DE69720185D1 (de) | Verdunsterkarussell | |
| ID24110A (id) | Pembuatan rutenium kompleks | |
| ID20403A (id) | PEMBUATAN α-TOKOFEROL | |
| ID20897A (id) | Susunan penutup-rapat | |
| FI970798A0 (fi) | List foer en avvattningsanordning i en pappersmaskin | |
| DE69838302D1 (de) | Gruppenlaufzeitentzerrer | |
| ID23663A (id) | Persiapan kaprolaktam | |
| FI972138A0 (fi) | Returtraog i bestrykningsanordning | |
| ATA86797A (de) | Verschleissschuh | |
| ATA46498A (de) | Kunststoffgleitbahn | |
| FI972751A (fi) | Ääntä hajottava soladiffusorirakenne | |
| ITDP970013A1 (it) | Ruota singola - attrezzo sportivo - cicloidi | |
| ATA159297A (de) | Immuntolerante prothrombinkomplex-präparation | |
| FI974635A0 (fi) | I vaermebatteri integrerbar ventilkonstruktion | |
| FI974373A0 (fi) | Avgasutlopp i utombordsmotorer | |
| FI974354A0 (fi) | Kvaevereducering i avloppsvatten | |
| FI972997A0 (fi) | Anordning i en sugsamlarvagn | |
| FI972891A0 (fi) | I en vaeggkonstruktion infaellbart faerdigt elkanalnaet | |
| FI972640A0 (fi) | Gapformare i en pappersmaskin/kartongmaskin |